Market Cap 355.31B
Revenue (ttm) 61.16B
Net Income (ttm) 4.23B
EPS (ttm) N/A
PE Ratio 20.05
Forward PE 14.10
Profit Margin 6.91%
Debt to Equity Ratio -20.91
Volume 7,605,800
Avg Vol 6,933,976
Day's Range N/A - N/A
Shares Out 1.77B
Stochastic %K 10%
Beta 0.38
Analysts Strong Sell
Price Target $250.10

Company Profile

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 847 932 7900
Address:
1 North Waukegan Road, North Chicago, United States
jbops3
jbops3 Apr. 24 at 11:32 PM
$ABBV my children, a pe of 83 is extraordinarily high for a pharma company. the only way that would make sense is if abbvie found a cure for cancer. has abbvie found a cure for cancer?
1 · Reply
UsingAGodAlgorithm
UsingAGodAlgorithm Apr. 24 at 10:18 PM
$SE (-75% from short entry) We are the best on ST as far as we have seen. Check our profile We also covered these names. $ABBV $PLTR $MU $MA
0 · Reply
Donib11
Donib11 Apr. 24 at 7:59 PM
$ABBV 210+ by end of next week easy
0 · Reply
Donib11
Donib11 Apr. 24 at 7:54 PM
$ABBV guys, take a look at @jbops3 post history. All his bearish calls end up being tremendously bullish. This means we will be up big soon!!!
1 · Reply
LongJohnOption
LongJohnOption Apr. 24 at 7:52 PM
$ABBV miserable
0 · Reply
jbops3
jbops3 Apr. 24 at 7:32 PM
$ABBV my children, we are almost to the finish line. i would be so proud of you if we can finish below 195 today, i know i can count on you. there is absolutely no reason for this to ever hit 200 again. if there is, then please do kindly share it with me on this thread. but i am confident that there will be no such responses as i only speak the absolute truth. bulls are only beginning to capitulate. only bad news lie ahead for this company. but the most daunting part is its significantly lower forward pe, i havent seen anything more sinister than that. come monday this will tank like theres no tomorrow. free yourselves from this evil. monday this will open at 189. mark this post.
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Apr. 24 at 6:37 PM
$SLS $ABBV $RVMD a Basic Fact Everyone should understand: Harvard Prof., Dr. Amrein enhanced dosing, increasing Potency, above and beyond the Phase 2B Results Published at ASH - Virtually Guarantees SLS009 FDA APPROVAL for a BUYER - Results in the Ongoing RANDOMIZED Pivotal P2B Expansion into Front Line AML-MR - will be better than the Previous Results - in end stage.
0 · Reply
Luckyjs38
Luckyjs38 Apr. 24 at 4:30 PM
0 · Reply
Luckyjs38
Luckyjs38 Apr. 24 at 4:21 PM
$ENVB know what you hold IND sends it $ABBV knows our true value im adding thanks shorts
0 · Reply
Donib11
Donib11 Apr. 24 at 3:59 PM
$ABBV GO BACK ABOVE 200 RIGHT NOW 😡
0 · Reply
Latest News on ABBV
US FDA declines to approve AbbVie's wrinkle treatment

Apr 23, 2026, 4:19 PM EDT - 1 day ago

US FDA declines to approve AbbVie's wrinkle treatment


Erin Lichy Gets Real About Her Natrelle® Breast Augmentation

Apr 14, 2026, 8:50 AM EDT - 11 days ago

Erin Lichy Gets Real About Her Natrelle® Breast Augmentation


AbbVie to Host First-Quarter 2026 Earnings Conference Call

Mar 31, 2026, 8:00 AM EDT - 25 days ago

AbbVie to Host First-Quarter 2026 Earnings Conference Call


Buy Or Fear AbbVie Stock At $210?

Mar 19, 2026, 9:26 AM EDT - 5 weeks ago

Buy Or Fear AbbVie Stock At $210?


AbbVie Transcript: Leerink Global Healthcare Conference 2026

Mar 10, 2026, 11:20 AM EDT - 6 weeks ago

AbbVie Transcript: Leerink Global Healthcare Conference 2026


AbbVie Transcript: TD Cowen 46th Annual Health Care Conference

Mar 3, 2026, 11:10 AM EST - 7 weeks ago

AbbVie Transcript: TD Cowen 46th Annual Health Care Conference


AbbVie Declares Quarterly Dividend

Feb 19, 2026, 9:37 AM EST - 2 months ago

AbbVie Declares Quarterly Dividend


AbbVie sues US health agency over Botox price controls

Feb 11, 2026, 6:49 PM EST - 2 months ago

AbbVie sues US health agency over Botox price controls


Abbvie sues US health agency over Botox

Feb 11, 2026, 5:13 PM EST - 2 months ago

Abbvie sues US health agency over Botox


AbbVie Earnings Call Transcript: Q4 2025

Feb 4, 2026, 9:00 AM EST - 2 months ago

AbbVie Earnings Call Transcript: Q4 2025


AbbVie Revenue Rises on Immunology Growth

Feb 4, 2026, 8:34 AM EST - 2 months ago

AbbVie Revenue Rises on Immunology Growth


AbbVie Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 11:15 AM EST - 3 months ago

AbbVie Transcript: 44th Annual J.P. Morgan Healthcare Conference


AbbVie Transcript: 7th Annual Healthcare Symposium

Nov 14, 2025, 11:55 AM EST - 5 months ago

AbbVie Transcript: 7th Annual Healthcare Symposium


AbbVie Earnings Call Transcript: Q3 2025

Oct 31, 2025, 9:00 AM EDT - 6 months ago

AbbVie Earnings Call Transcript: Q3 2025


AbbVie Earnings Call Transcript: Q2 2025

Jul 31, 2025, 9:00 AM EDT - 9 months ago

AbbVie Earnings Call Transcript: Q2 2025


AbbVie Transcript: BofA Securities 2025 Healthcare Conference

May 14, 2025, 1:00 PM EDT - 1 year ago

AbbVie Transcript: BofA Securities 2025 Healthcare Conference


AbbVie Transcript: AGM 2025

May 9, 2025, 10:00 AM EDT - 1 year ago

AbbVie Transcript: AGM 2025


AbbVie Earnings Call Transcript: Q1 2025

Apr 25, 2025, 9:00 AM EDT - 1 year ago

AbbVie Earnings Call Transcript: Q1 2025


AbbVie Earnings Call Transcript: Q4 2024

Jan 31, 2025, 9:00 AM EST - 1 year ago

AbbVie Earnings Call Transcript: Q4 2024


AbbVie Transcript: Citi's 2024 Global Healthcare Conference

Dec 3, 2024, 10:15 AM EST - 1 year ago

AbbVie Transcript: Citi's 2024 Global Healthcare Conference


AbbVie Earnings Call Transcript: Q3 2024

Oct 30, 2024, 9:00 AM EDT - 1 year ago

AbbVie Earnings Call Transcript: Q3 2024


AbbVie Earnings Call Transcript: Q2 2024

Jul 25, 2024, 9:00 AM EDT - 1 year ago

AbbVie Earnings Call Transcript: Q2 2024


AbbVie Transcript: BofA Securities 2024 Health Care Conference

May 15, 2024, 1:40 PM EDT - 2 years ago

AbbVie Transcript: BofA Securities 2024 Health Care Conference


AbbVie Transcript: ASM 2024

May 3, 2024, 10:00 AM EDT - 2 years ago

AbbVie Transcript: ASM 2024


AbbVie Earnings Call Transcript: Q1 2024

Apr 26, 2024, 9:00 AM EDT - 2 years ago

AbbVie Earnings Call Transcript: Q1 2024


AbbVie Earnings Call Transcript: Q4 2023

Feb 2, 2024, 9:00 AM EST - 2 years ago

AbbVie Earnings Call Transcript: Q4 2023


AbbVie Transcript: M&A Announcement

Dec 7, 2023, 9:00 AM EST - 2 years ago

AbbVie Transcript: M&A Announcement


AbbVie Transcript: M&A Announcement

Nov 30, 2023, 9:00 AM EST - 2 years ago

AbbVie Transcript: M&A Announcement


AbbVie Earnings Call Transcript: Q3 2023

Oct 27, 2023, 9:00 AM EDT - 2 years ago

AbbVie Earnings Call Transcript: Q3 2023


AbbVie Earnings Call Transcript: Q2 2023

Jul 27, 2023, 9:00 AM EDT - 2 years ago

AbbVie Earnings Call Transcript: Q2 2023


AbbVie Transcript: Bank of America Global Healthcare Conference

May 9, 2023, 11:00 AM EDT - 3 years ago

AbbVie Transcript: Bank of America Global Healthcare Conference


AbbVie Earnings Call Transcript: Q1 2023

Apr 27, 2023, 9:00 AM EDT - 3 years ago

AbbVie Earnings Call Transcript: Q1 2023


AbbVie Transcript: Barclays Global Healthcare Conference

Mar 15, 2023, 1:35 PM EDT - 3 years ago

AbbVie Transcript: Barclays Global Healthcare Conference


AbbVie Transcript: Cowen Health Care Conference

Mar 7, 2023, 9:10 AM EST - 3 years ago

AbbVie Transcript: Cowen Health Care Conference


AbbVie Earnings Call Transcript: Q4 2022

Feb 9, 2023, 9:00 AM EST - 3 years ago

AbbVie Earnings Call Transcript: Q4 2022


AbbVie Transcript: JPMorgan Healthcare Conference

Jan 10, 2023, 6:00 PM EST - 3 years ago

AbbVie Transcript: JPMorgan Healthcare Conference


AbbVie Earnings Call Transcript: Q3 2022

Oct 28, 2022, 9:00 AM EDT - 3 years ago

AbbVie Earnings Call Transcript: Q3 2022


AbbVie Earnings Call Transcript: Q2 2022

Jul 29, 2022, 6:27 AM EDT - 4 years ago

AbbVie Earnings Call Transcript: Q2 2022


AbbVie Earnings Call Transcript: Q1 2022

Apr 29, 2022, 12:59 PM EDT - 4 years ago

AbbVie Earnings Call Transcript: Q1 2022


AbbVie Earnings Call Transcript: Q4 2021

Feb 2, 2022, 2:50 PM EST - 4 years ago

AbbVie Earnings Call Transcript: Q4 2021


AbbVie Transcript: J.P. Morgan Healthcare Conference

Jan 11, 2022, 5:44 AM EST - 4 years ago

AbbVie Transcript: J.P. Morgan Healthcare Conference


AbbVie Earnings Call Transcript: Q3 2021

Oct 28, 2021, 8:00 PM EDT - 4 years ago

AbbVie Earnings Call Transcript: Q3 2021


AbbVie Earnings Call Transcript: Q2 2021

Jul 29, 2021, 8:20 PM EDT - 5 years ago

AbbVie Earnings Call Transcript: Q2 2021


AbbVie Transcript: ASM 2021

May 7, 2021, 5:53 AM EDT - 5 years ago

AbbVie Transcript: ASM 2021


AbbVie Earnings Call Transcript: Q1 2021

Apr 30, 2021, 8:42 AM EDT - 5 years ago

AbbVie Earnings Call Transcript: Q1 2021


AbbVie Earnings Call Transcript: Q4 2020

Feb 3, 2021, 9:00 AM EST - 5 years ago

AbbVie Earnings Call Transcript: Q4 2020


AbbVie Transcript: Strategy Update

Dec 14, 2020, 10:00 AM EST - 5 years ago

AbbVie Transcript: Strategy Update


AbbVie Earnings Call Transcript: Q3 2020

Oct 30, 2020, 9:00 AM EDT - 5 years ago

AbbVie Earnings Call Transcript: Q3 2020


AbbVie Earnings Call Transcript: Q2 2020

Jul 31, 2020, 9:00 AM EDT - 6 years ago

AbbVie Earnings Call Transcript: Q2 2020


AbbVie Transcript: ASM 2020

May 8, 2020, 10:00 AM EDT - 6 years ago

AbbVie Transcript: ASM 2020


AbbVie Earnings Call Transcript: Q1 2020

May 1, 2020, 9:00 AM EDT - 6 years ago

AbbVie Earnings Call Transcript: Q1 2020


AbbVie Earnings Call Transcript: Q4 2019

Feb 7, 2020, 9:00 AM EST - 6 years ago

AbbVie Earnings Call Transcript: Q4 2019


AbbVie Earnings Call Transcript: Q3 2019

Nov 1, 2019, 9:00 AM EDT - 7 years ago

AbbVie Earnings Call Transcript: Q3 2019


AbbVie Earnings Call Transcript: Q2 2019

Jul 26, 2019, 9:00 AM EDT - 7 years ago

AbbVie Earnings Call Transcript: Q2 2019


AbbVie Transcript: M&A Announcement

Jun 25, 2019, 8:30 AM EDT - 7 years ago

AbbVie Transcript: M&A Announcement


AbbVie Earnings Call Transcript: Q1 2019

Apr 25, 2019, 9:00 AM EDT - 7 years ago

AbbVie Earnings Call Transcript: Q1 2019


AbbVie Earnings Call Transcript: Q4 2018

Jan 25, 2019, 9:00 AM EST - 7 years ago

AbbVie Earnings Call Transcript: Q4 2018


AbbVie Earnings Call Transcript: Q3 2018

Nov 2, 2018, 9:00 AM EDT - 8 years ago

AbbVie Earnings Call Transcript: Q3 2018


AbbVie Earnings Call Transcript: Q2 2018

Jul 27, 2018, 9:00 AM EDT - 8 years ago

AbbVie Earnings Call Transcript: Q2 2018


AbbVie Earnings Call Transcript: Q1 2018

Apr 26, 2018, 9:00 AM EDT - 8 years ago

AbbVie Earnings Call Transcript: Q1 2018


AbbVie Earnings Call Transcript: Q4 2017

Jan 26, 2018, 9:00 AM EST - 8 years ago

AbbVie Earnings Call Transcript: Q4 2017


AbbVie Earnings Call Transcript: Q3 2017

Oct 27, 2017, 9:00 AM EDT - 9 years ago

AbbVie Earnings Call Transcript: Q3 2017


AbbVie Earnings Call Transcript: Q2 2017

Jul 28, 2017, 9:00 AM EDT - 9 years ago

AbbVie Earnings Call Transcript: Q2 2017


AbbVie Earnings Call Transcript: Q1 2017

Apr 27, 2017, 9:00 AM EDT - 9 years ago

AbbVie Earnings Call Transcript: Q1 2017


AbbVie Earnings Call Transcript: Q4 2016

Jan 27, 2017, 9:00 AM EST - 10 years ago

AbbVie Earnings Call Transcript: Q4 2016


AbbVie Earnings Call Transcript: Q3 2016

Oct 28, 2016, 9:00 AM EDT - 10 years ago

AbbVie Earnings Call Transcript: Q3 2016


AbbVie Earnings Call Transcript: Q2 2016

Jul 29, 2016, 9:00 AM EDT - 10 years ago

AbbVie Earnings Call Transcript: Q2 2016


AbbVie Transcript: R&D Day 2016

Jun 3, 2016, 10:00 AM EDT - 10 years ago

AbbVie Transcript: R&D Day 2016


AbbVie Earnings Call Transcript: Q1 2016

Apr 28, 2016, 9:00 AM EDT - 10 years ago

AbbVie Earnings Call Transcript: Q1 2016


AbbVie Earnings Call Transcript: Q4 2015

Jan 29, 2016, 9:00 AM EST - 11 years ago

AbbVie Earnings Call Transcript: Q4 2015


AbbVie Earnings Call Transcript: Q3 2015

Oct 30, 2015, 10:00 AM EDT - 11 years ago

AbbVie Earnings Call Transcript: Q3 2015


AbbVie Earnings Call Transcript: Q2 2015

Jul 24, 2015, 9:00 AM EDT - 11 years ago

AbbVie Earnings Call Transcript: Q2 2015


AbbVie Earnings Call Transcript: Q1 2015

Apr 23, 2015, 9:00 AM EDT - 11 years ago

AbbVie Earnings Call Transcript: Q1 2015


AbbVie Transcript: M&A Announcement

Mar 5, 2015, 9:00 AM EST - 12 years ago

AbbVie Transcript: M&A Announcement


AbbVie Earnings Call Transcript: Q4 2014

Jan 30, 2015, 9:00 AM EST - 12 years ago

AbbVie Earnings Call Transcript: Q4 2014


AbbVie Earnings Call Transcript: Q3 2014

Oct 31, 2014, 9:00 AM EDT - 12 years ago

AbbVie Earnings Call Transcript: Q3 2014


AbbVie Earnings Call Transcript: Q2 2014

Jul 25, 2014, 9:00 AM EDT - 12 years ago

AbbVie Earnings Call Transcript: Q2 2014


AbbVie Earnings Call Transcript: Q1 2014

Apr 25, 2014, 9:00 AM EDT - 13 years ago

AbbVie Earnings Call Transcript: Q1 2014


AbbVie Earnings Call Transcript: Q4 2013

Jan 31, 2014, 9:00 AM EST - 13 years ago

AbbVie Earnings Call Transcript: Q4 2013


AbbVie Earnings Call Transcript: Q3 2013

Oct 25, 2013, 9:00 AM EDT - 13 years ago

AbbVie Earnings Call Transcript: Q3 2013


AbbVie Earnings Call Transcript: Q2 2013

Jul 26, 2013, 9:00 AM EDT - 13 years ago

AbbVie Earnings Call Transcript: Q2 2013


AbbVie Earnings Call Transcript: Q1 2013

Apr 26, 2013, 9:00 AM EDT - 14 years ago

AbbVie Earnings Call Transcript: Q1 2013


AbbVie Earnings Call Transcript: Q4 2012

Jan 30, 2013, 9:00 AM EST - 14 years ago

AbbVie Earnings Call Transcript: Q4 2012


jbops3
jbops3 Apr. 24 at 11:32 PM
$ABBV my children, a pe of 83 is extraordinarily high for a pharma company. the only way that would make sense is if abbvie found a cure for cancer. has abbvie found a cure for cancer?
1 · Reply
UsingAGodAlgorithm
UsingAGodAlgorithm Apr. 24 at 10:18 PM
$SE (-75% from short entry) We are the best on ST as far as we have seen. Check our profile We also covered these names. $ABBV $PLTR $MU $MA
0 · Reply
Donib11
Donib11 Apr. 24 at 7:59 PM
$ABBV 210+ by end of next week easy
0 · Reply
Donib11
Donib11 Apr. 24 at 7:54 PM
$ABBV guys, take a look at @jbops3 post history. All his bearish calls end up being tremendously bullish. This means we will be up big soon!!!
1 · Reply
LongJohnOption
LongJohnOption Apr. 24 at 7:52 PM
$ABBV miserable
0 · Reply
jbops3
jbops3 Apr. 24 at 7:32 PM
$ABBV my children, we are almost to the finish line. i would be so proud of you if we can finish below 195 today, i know i can count on you. there is absolutely no reason for this to ever hit 200 again. if there is, then please do kindly share it with me on this thread. but i am confident that there will be no such responses as i only speak the absolute truth. bulls are only beginning to capitulate. only bad news lie ahead for this company. but the most daunting part is its significantly lower forward pe, i havent seen anything more sinister than that. come monday this will tank like theres no tomorrow. free yourselves from this evil. monday this will open at 189. mark this post.
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Apr. 24 at 6:37 PM
$SLS $ABBV $RVMD a Basic Fact Everyone should understand: Harvard Prof., Dr. Amrein enhanced dosing, increasing Potency, above and beyond the Phase 2B Results Published at ASH - Virtually Guarantees SLS009 FDA APPROVAL for a BUYER - Results in the Ongoing RANDOMIZED Pivotal P2B Expansion into Front Line AML-MR - will be better than the Previous Results - in end stage.
0 · Reply
Luckyjs38
Luckyjs38 Apr. 24 at 4:30 PM
0 · Reply
Luckyjs38
Luckyjs38 Apr. 24 at 4:21 PM
$ENVB know what you hold IND sends it $ABBV knows our true value im adding thanks shorts
0 · Reply
Donib11
Donib11 Apr. 24 at 3:59 PM
$ABBV GO BACK ABOVE 200 RIGHT NOW 😡
0 · Reply
profit_guru
profit_guru Apr. 24 at 3:52 PM
$ABBV - way oversold …might close green…imo
0 · Reply
BullProphet
BullProphet Apr. 24 at 3:34 PM
The obesity space is starting to look like a full-on pipeline war between pharma giants… $ABBV is effectively building an “options portfolio” in obesity — not just one asset, but multiple shots on goal across mechanisms, formats, and durations. Same strategic logic applies (to varying degrees) for $AMGN, $NVO, and the rest of the field — but execution paths are diverging fast. Key divide right now: Importing molecules from China with limited Western tolerability + trial consistency data vs. building fully US-validated clinical pipelines with cleaner regulatory paths and higher predictability. The current read-through from $NVO vs $LLY oral data is important — it’s highlighting where differentiation actually matters: tolerability + mechanism efficiency + adherence, not just headline efficacy. Does VKTX share everything to maximize market validation… or optimize for strategic positioning first? That answer may shape repricing across the entire obesity stack.
0 · Reply
crtlabz
crtlabz Apr. 24 at 3:16 PM
$ABBV hard to find green days
0 · Reply
jbops3
jbops3 Apr. 24 at 2:33 PM
$ABBV my children, im very proud of you all. thank you for heeding to my words. i only speak the truth and you can have faith in my guidance. a stock that has a drastically lower forward pe is a target for shorting destruction. lower pe = lower market cap. so you tell me if this is heading towards sub $180 very soon. we might even get there by the eod today. lets keep up the good work. if you missed the 200 train, then dont panic, you still have time to escape. dont let the 190 train pass you by. cut your losses and move on from this scam dime a dozen pharma. you all deserve better.
0 · Reply
TeenageMutantNinjaTrader
TeenageMutantNinjaTrader Apr. 24 at 2:25 PM
$ABBV wtf
0 · Reply
Whiskeyunderthebed
Whiskeyunderthebed Apr. 24 at 1:42 PM
$ABBV finally broke $200...I'm NOT sure how low they can push this, but I'm waiting to add a boat load.
0 · Reply
OpenOutcrier
OpenOutcrier Apr. 24 at 12:25 PM
$ABBV (-0.5% pre) US FDA rejects AbbVie's wrinkle treatment due to manufacturing concerns https://ooc.bz/l/99899
0 · Reply
theDIOyears
theDIOyears Apr. 24 at 12:25 AM
$ABBV where we goin tomorrow? I'm thinking 195, I will buy the fear. CMC questions, not safety or efficacy. With earnings coming up let's see what they can do.
0 · Reply
StocktwitsNews
StocktwitsNews Apr. 23 at 11:26 PM
REGN Becomes Final Major Drugmaker To Sign Trump’s Drug Pricing Pledge $REGN $LLY $GSK $ABBV $AMGN https://stocktwits.com/news/equity/markets/regn-becomes-final-major-drugmaker-to-sign-trump-s-drug-pricing-pledge/cZBQQQSReT5
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Apr. 23 at 11:07 PM
$SLS $ABBV Don't Lose sight of the forest through the trees. $.88 share price WHEN the IDMC released Unblinded actual Phase 3 Interim Analysis MOS and IR data - when the IDMC informed Players ​a $13.5M cash, a $77M Mcap Today were pushing $5 and are a $880M MCAP with $125M Cash in the Bank -- BAT AzaVEN Failed 3 large Phase 3 Trials for AML Since then too. $ABBV Knows precisely how Aza+VEN doesn't work for AML Remission Maintenance - the VIALE-M CR1 Maintenance trial FAILED ... ALL SLS p3 Patients were enrolled a solid 25 months ago - there are No Published Trials w any CR2 Survival past 24 months, none.. . . . +/- 60 EVENTS at Least From the Control Arm - while we await 80 Gps proved effective at Preventing Relapse and Extending survival in all prior trials, including 2 Phase 2 Trials for AML Remission +2x and 4X OS Advantage. ITS NOT COMPLICATED
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Apr. 23 at 10:36 PM
$SLS $XBI $ABBV $125M Cash on Hand - RUNWAY INTO 2030.
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Apr. 23 at 10:31 PM
$SLS $PFE $LLY $ABBV $SLS for the passersby Just the secondary asset - SLS009 is worth $27 Per Share / pardon $24.47 Per Share - right now.
0 · Reply